Cargando…

Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

Galectin-3 has a relatively high level of expression in triple-negative breast cancers and is a potential marker for this disease. However, the clinical and prognostic implications of galectin-3 expression in breast cancer remain unclear. We examined mastectomy specimens from 1086 breast cancer case...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Hao, Liang, Xi, Duan, Chao, Liu, Caigang, Zhao, Zuowei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177814/ https://www.ncbi.nlm.nih.gov/pubmed/25254965 http://dx.doi.org/10.1371/journal.pone.0103482

Ejemplares similares

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2020)

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
Publicado: (2015)

Galectins as New Prognostic Markers and Potential Therapeutic Targets for Advanced Prostate Cancers
por: Laderach, Diego J., et al.
Publicado: (2013)

Serum Galectin-3 as a Potential Marker for Gastric Cancer
por: Cheng, Daye, et al.
Publicado: (2015)

Galectins—Potential Therapeutic Targets for Neurodegenerative Disorders
por: Chaudhary, Sapana, et al.
Publicado: (2022)

CEMIP as a potential biomarker and therapeutic target for breast cancer patients
por: Xue, Jinqi, et al.
Publicado: (2022)

The role of galectins-1, 3, 7, 8 and 9 as potential diagnostic and therapeutic markers in ovarian cancer
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2022)

Influence of wound fluid on chemotherapy sensitivity in primary breast cancer cells
por: Zhang, Yingchao, et al.
Publicado: (2016)

Galectin-3, Possible Role in Pathogenesis of Periodontal Diseases and Potential Therapeutic Target
por: Velickovic, Milica, et al.
Publicado: (2021)

431 Galectin-3 as a Biomarker and Potential Therapeutic Target in Biliary Atresia
por: Yoeli, Dor, et al.
Publicado: (2022)

Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseases
por: Nangia-Makker, Pratima, et al.
Publicado: (2022)

Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target
por: Capone, Emily, et al.
Publicado: (2021)

Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells
por: Zhao, Zuowei, et al.
Publicado: (2014)

Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker?
por: Soccio, Raymond E
Publicado: (2021)

The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
por: Sygitowicz, Grażyna, et al.
Publicado: (2021)

Galectin-3 as a Potential Target to Prevent Cancer Metastasis
por: Ahmed, Hafiz, et al.
Publicado: (2015)

Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
por: Wang, Dan, et al.
Publicado: (2014)

Correction: Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients
por: Wang, Dan, et al.
Publicado: (2021)

Primary malignant fibrous histiocytoma of the breast: report of one case
por: Liu, Caigang, et al.
Publicado: (2013)

Galectins as Molecular Targets for Therapeutic Intervention
por: Dings, Ruud P. M., et al.
Publicado: (2018)

Expression and clinicopathological significance of FSIP1 in breast cancer
por: Zhang, Hao, et al.
Publicado: (2015)

Galectin-1 as a potential cancer target
por: Rabinovich, G A
Publicado: (2005)

Galectin-3 inhibition as a potential therapeutic target in non-alcoholic steatohepatitis liver fibrosis
por: Kram, Michael
Publicado: (2023)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Kong, Fei, et al.
Publicado: (2020)

Galectin signatuares contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
por: Grosset, Andrée-Anne, et al.
Publicado: (2016)

Galectin-3 as a Therapeutic Target for NSAID-Induced Intestinal Ulcers
por: Park, Ah-Mee, et al.
Publicado: (2020)

Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases
por: Ahmed, Rakin, et al.
Publicado: (2023)

Use of Glycoproteins—Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of Metastatic Prostate Cancer
por: Sharma, Satish, et al.
Publicado: (2022)

Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer
por: Upreti, Meenakshi, et al.
Publicado: (2016)

Clinical implications of SPRR1A expression in diffuse large B-cell lymphomas: a prospective, observational study
por: Zhang, Hao, et al.
Publicado: (2014)

Galectin-3 Regulates the Expression of Tumor Glycosaminoglycans and Increases the Metastatic Potential of Breast Cancer
por: Pereira, Jonathas Xavier, et al.
Publicado: (2019)

The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic Cholangiocarcinoma Patients and Those Compromised With COVID-19
por: Li, Hao, et al.
Publicado: (2021)

Highlights on the Role of Galectin-3 in Colorectal Cancer and the Preventive/Therapeutic Potential of Food-Derived Inhibitors
por: Aureli, Anna, et al.
Publicado: (2022)

Galectins as Emerging Glyco-Checkpoints and Therapeutic Targets in Glioblastoma
por: Videla-Richardson, Guillermo A., et al.
Publicado: (2021)

Galectin-8 induces functional disease markers in human osteoarthritis and cooperates with galectins-1 and -3
por: Weinmann, Daniela, et al.
Publicado: (2018)

The Role of Galectin-3 in Retinal Degeneration and Other Ocular Diseases: A Potential Novel Biomarker and Therapeutic Target
por: Zhou, Ziyi, et al.
Publicado: (2023)

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
por: Zhu, Xudong, et al.
Publicado: (2020)

Analysis of TRRAP as a Potential Molecular Marker and Therapeutic Target for Breast Cancer
por: Wang, Ji, et al.
Publicado: (2016)

Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
por: Grönberg, Malin, et al.
Publicado: (2017)

Galectin-3: its role in asthma and potential as an anti-inflammatory target
por: Gao, Peng, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_t5nh8ljqi3v61odgvgtrkovre3